In fact, these failures may be explained in light of the fact that another cytokine, the leukemia inhibitory factor (LIF), has been shown to be involved in cancer cachexia at least in rodent models and to be dominant over IL-6 [81]. The gene discussed is LIF; the disease is Cachexia.